| Under the Standing Offer Health Specific Business Case Development Pre-Approved Provider Arrangement SOA MNHHS82530, Metro North Hospital and Health Service (MNHHS) invites submissions for Detailed Business Case Development (Gate 2) Genomics Institute.
In 2017 MNHHS developed a strategic business case to identify the mechanism for bringing translational genomics research into clinical practice in the Queensland Health System.
The Genomic Institute was conceived as part of the strategic vision for the Herston Health Precinct.
MNHHS require development of a Gate 2 Detailed Business Case for the establishment of a Genomics Institute located at Herston Health Precinct in accordance with the Department of Health Investment Management Framework.
For further information and requirements definition refer to RFQ documentation.
Closing Date: Monday 1st February 2021 at 2:00PM (AEST)
|
